Pharmacological treatments available in Brazil for multiple sclerosis patients: Integrative review
International Journal of Development Research
Pharmacological treatments available in Brazil for multiple sclerosis patients: Integrative review
Renata Abílio Diniz Leite Medeiros
Received 19th September, 2022; Received in revised form 25th September, 2022; Accepted 06th October, 2022; Published online 30th October, 2022
Introduction: Multiple sclerosis (MS) affects a large number of people worldwide, in Brazil the estimate is 40,000 people who have the disease. There is no cure for multiple sclerosis, but currently there are several treatments available both by the public network and by the private network in Brazil. Objective: It is to know the pharmacological treatments available in Brazil for patients with multiple sclerosis. Methodology: Fhi an integrative review of the literature, in the Databases PubMed, capes and VHL. Result and discussion: Treatment for multiple sclerosis is divided into imunomodulators that are considered the first-line drugs and exist the second-line. Conclusion: Thes medications are effective in controlling multiple sclerosis.